Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor-α inhibitor infliximab

被引：66

作者：

Jacobi, A

Schuler, G

Hertl, M

机构：

[1] Univ Hosp Erlangen, Dept Dermatol, D-91052 Erlangen, Germany

[2] Univ Hosp Marburg, Dept Dermatol, D-35037 Marburg, Germany

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2005年 / 153卷 / 02期

关键词：

D O I：

10.1111/j.1365-2133.2005.06744.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：448 / 449

页数：3

共 7 条

[1] In vitro and In vivo expression of interleukin-1α and tumor necrosis factor-α mRNA in pemphigus vulgaris:: Interleukin-1α and tumor necrosis factor-α are involved in acantholysis [J].

Feliciani, C ;

Toto, P ;

Amerio, P ;

Pour, SM ;

Coscione, G ;

Amerio, P ;

Shivji, G ;

Wang, BH ;

Sauder, DN .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (01) :71-77

[2]

Jacobi Arnd, 2003, J Dtsch Dermatol Ges, V1, P259, DOI 10.1046/j.1610-0387.2003.02044.x

[3] CONSTRUCTION AND INITIAL CHARACTERIZATION OF A MOUSE-HUMAN CHIMERIC ANTI-TNF ANTIBODY [J].

KNIGHT, DM ;

TRINH, H ;

LE, JM ;

SIEGEL, S ;

SHEALY, D ;

MCDONOUGH, M ;

SCALLON, B ;

MOORE, MA ;

VILCEK, J ;

DADDONA, P ;

GHRAYEB, J .

MOLECULAR IMMUNOLOGY, 1993, 30 (16) :1443-1453

[4] TNFα and IL-6 are mediators in the blistering process of pemphigus [J].

López-Robles, E ;

Avalos-Díaz, E ;

Vega-Memije, E ;

Hojyo-Tomoka, T ;

Villalobos, R ;

Fraire, S ;

Domíguez-Soto, L ;

Herrera-Esparza, R .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2001, 40 (03) :185-188

[5] Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate:: a randomised phase III trial [J].

Maini, R ;

St Clair, EW ;

Breedveld, F ;

Furst, D ;

Kalden, J ;

Weisman, M ;

Smolen, J ;

Emery, P ;

Harriman, G ;

Feldmann, M ;

Lipsky, P .

LANCET, 1999, 354 (9194) :1932-1939

[6] Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors [J].

Mease, PJ .

ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (04) :298-304

[7] Infliximab maintenance therapy for fistulizing Crohn's disease [J].

Sands, BE ;

Anderson, FH ;

Bernstein, CN ;

Chey, WY ;

Feagan, BG ;

Fedorak, RN ;

Kamm, MA ;

Korzenik, JR ;

Lashner, BA ;

Onken, JE ;

Rachmilewitz, D ;

Rutgeerts, P ;

Wild, G ;

Wolf, DC ;

Marsters, PA ;

Travers, SB ;

Blank, MA ;

van Deventer, SJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (09) :876-885

← 1 →